101 related articles for article (PubMed ID: 28368607)
1. Enantiospecific Recognition at the A
Carbajales C; Azuaje J; Oliveira A; Loza MI; Brea J; Cadavid MI; Masaguer CF; García-Mera X; Gutiérrez-de-Terán H; Sotelo E
J Med Chem; 2017 Apr; 60(8):3372-3382. PubMed ID: 28368607
[TBL] [Abstract][Full Text] [Related]
2. 3,4-Dihydropyrimidin-2(1
Majellaro M; Jespers W; Crespo A; Núñez MJ; Novio S; Azuaje J; Prieto-Díaz R; Gioé C; Alispahic B; Brea J; Loza MI; Freire-Garabal M; Garcia-Santiago C; Rodríguez-García C; García-Mera X; Caamaño O; Fernandez-Masaguer C; Sardina JF; Stefanachi A; El Maatougui A; Mallo-Abreu A; Åqvist J; Gutiérrez-de-Terán H; Sotelo E
J Med Chem; 2021 Jan; 64(1):458-480. PubMed ID: 33372800
[TBL] [Abstract][Full Text] [Related]
3. Trifluorinated Pyrimidine-Based A
Mallo-Abreu A; Majellaro M; Jespers W; Azuaje J; Caamaño O; García-Mera X; Brea JM; Loza MI; Gutiérrez-de-Terán H; Sotelo E
J Med Chem; 2019 Oct; 62(20):9315-9330. PubMed ID: 31557025
[TBL] [Abstract][Full Text] [Related]
4. Identification of V6.51L as a selectivity hotspot in stereoselective A
Wang X; Jespers W; Prieto-Díaz R; Majellaro M; IJzerman AP; van Westen GJP; Sotelo E; Heitman LH; Gutiérrez-de-Terán H
Sci Rep; 2021 Jul; 11(1):14171. PubMed ID: 34238993
[TBL] [Abstract][Full Text] [Related]
5. Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A
Mallo-Abreu A; Prieto-Díaz R; Jespers W; Azuaje J; Majellaro M; Velando C; García-Mera X; Caamaño O; Brea J; Loza MI; Gutiérrez-de-Terán H; Sotelo E
J Med Chem; 2020 Jul; 63(14):7721-7739. PubMed ID: 32573250
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel xanthine derivatives as potent and selective A
Basu S; Barawkar DA; Ramdas V; Patel M; Waman Y; Panmand A; Kumar S; Thorat S; Naykodi M; Goswami A; Reddy BS; Prasad V; Chaturvedi S; Quraishi A; Menon S; Paliwal S; Kulkarni A; Karande V; Ghosh I; Mustafa S; De S; Jain V; Banerjee ER; Rouduri SR; Palle VP; Chugh A; Mookhtiar KA
Eur J Med Chem; 2017 Jul; 134():218-229. PubMed ID: 28415011
[TBL] [Abstract][Full Text] [Related]
7. Irreversible Antagonists for the Adenosine A
Temirak A; Schlegel JG; Voss JH; Vaaßen VJ; Vielmuth C; Claff T; Müller CE
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744918
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
9. Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A(1) adenosine receptor ligands.
Giovannoni MP; Vergelli C; Cilibrizzi A; Crocetti L; Biancalani C; Graziano A; Dal Piaz V; Loza MI; Cadavid MI; Díaz JL; Gavaldà A
Bioorg Med Chem; 2010 Nov; 18(22):7890-9. PubMed ID: 20937560
[TBL] [Abstract][Full Text] [Related]
10. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
Müller CE; Geis U; Grahner B; Lanzner W; Eger K
J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
[TBL] [Abstract][Full Text] [Related]
11. The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling.
Vecchio EA; Chuo CH; Baltos JA; Ford L; Scammells PJ; Wang BH; Christopoulos A; White PJ; May LT
Biochem Pharmacol; 2016 Oct; 117():46-56. PubMed ID: 27520486
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes.
El Maatougui A; Azuaje J; González-Gómez M; Miguez G; Crespo A; Carbajales C; Escalante L; García-Mera X; Gutiérrez-de-Terán H; Sotelo E
J Med Chem; 2016 Mar; 59(5):1967-83. PubMed ID: 26824742
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship of pyrazolo[3,4-d]pyrimidines: potent and selective adenosine A1 receptor antagonists.
Poulsen SA; Quinn RJ
J Med Chem; 1996 Oct; 39(21):4156-61. PubMed ID: 8863792
[TBL] [Abstract][Full Text] [Related]
14. Structure-affinity relationships of adenosine A2B receptor ligands.
Beukers MW; Meurs I; Ijzerman AP
Med Res Rev; 2006 Sep; 26(5):667-98. PubMed ID: 16847822
[TBL] [Abstract][Full Text] [Related]
15. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.
Pastorin G; Da Ros T; Spalluto G; Deflorian F; Moro S; Cacciari B; Baraldi PG; Gessi S; Varani K; Borea PA
J Med Chem; 2003 Sep; 46(20):4287-96. PubMed ID: 13678407
[TBL] [Abstract][Full Text] [Related]
16. Discovery and optimization of potent and selective functional antagonists of the human adenosine A2B receptor.
Bedford ST; Benwell KR; Brooks T; Chen I; Comer M; Dugdale S; Haymes T; Jordan AM; Kennett GA; Knight AR; Klenke B; LeStrat L; Merrett A; Misra A; Lightowler S; Padfield A; Poullennec K; Reece M; Simmonite H; Wong M; Yule IA
Bioorg Med Chem Lett; 2009 Oct; 19(20):5945-9. PubMed ID: 19733067
[TBL] [Abstract][Full Text] [Related]
17. Total Synthesis of Clerobungin A via a Cascade Cyclization Reaction.
Mease J; Reber KP
J Org Chem; 2016 Dec; 81(23):12006-12011. PubMed ID: 27934453
[TBL] [Abstract][Full Text] [Related]
18. Actinin-1 binds to the C-terminus of A2B adenosine receptor (A2BAR) and enhances A2BAR cell-surface expression.
Sun Y; Hu W; Yu X; Liu Z; Tarran R; Ravid K; Huang P
Biochem J; 2016 Jul; 473(14):2179-86. PubMed ID: 27208173
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
20. Enantiomeric 4-Acylamino-6-alkyloxy-2 Alkylthiopyrimidines As Potential A3 Adenosine Receptor Antagonists: HPLC Chiral Resolution and Absolute Configuration Assignment by a Full Set of Chiroptical Spectroscopy.
Rossi D; Nasti R; Marra A; Meneghini S; Mazzeo G; Longhi G; Memo M; Cosimelli B; Greco G; Novellino E; Da Settimo F; Martini C; Taliani S; Abbate S; Collina S
Chirality; 2016 May; 28(5):434-40. PubMed ID: 27095007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]